The Latest Trading Price of Archit Organosys Ltd is ₹ 37.88 as of 18 Mar 15:31
. The P/E Ratio of Archit Organosys Ltd is 10.9 as of March 2023
.The P/E Ratio of OCCL Ltd is 0 as of March 2023
. The Market Cap of Archit Organosys Ltd is ₹ 123.92 crore as of March 2023
.The Market Cap of OCCL Ltd is ₹ 0 crore as of March 2023
. The revenue of Archit Organosys Ltd for the Dec '25 is ₹ 39.3 crore as compare to the Sep '25 revenue of ₹ 34.32 crore. This represent the growth of 14.51% The revenue of OCCL Ltd for the Dec '25 is ₹ 114.62 crore as compare to the Sep '25 revenue of ₹ 120.62 crore. This represent the decline of -4.97% The ebitda of Archit Organosys Ltd for the Dec '25 is ₹ 5.58 crore as compare to the Sep '25 ebitda of ₹ 4.16 crore. This represent the growth of 34.13% The ebitda of OCCL Ltd for the Dec '25 is ₹ 17.06 crore as compare to the Sep '25 ebitda of ₹ 20.21 crore. This represent the decline of -15.59% The net profit of Archit Organosys Ltd changed from ₹ 1.01 crore to ₹ 2.43 crore over 7 quarters. This represents a CAGR of 65.15%
The net profit of OCCL Ltd changed from ₹ -0.04 crore to ₹ 6.53 crore over 7 quarters. This represents a CAGR of NaN%
The Dividend Payout of Archit Organosys Ltd changed from 14.99 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of OCCL Ltd changed from 34.98 % on March 2025 to 34.98 % on March 2025 . This represents a CAGR of 0.00% over 1 years .
About Archit Organosys Ltd
Archit Organosys Limited was originally incorporated on 04th August 1993 as 'Shri Chlochem Limited'.
The Company got the name changed to Archit Organosys Limited from Shri Chlochem Limited effective from 19th May, 2012.
The Company is mainly engaged in the business of manufacturing and trading of various chemical products.
Major customers of the Company include several large Indian and International companies who are engaged in the Agrochemical Manufacturing Sector, Pharmaceuticals Manufacturing Sector and Cosmetics Manufacturing Sector.
Company has developed various product like MCA, SMCA, CAC and TCAC. Company is selling their products across Pan India as well as USA, Europe, Latin America, Other Asian Countries and South Africa.
These products are used mainly in pharmaceutical Intermediates like Ibuprofen, Diclofenac, Aceclofenac, Oil field chemicals used for Oil Drilling mainly In CMC manufacturing, Agriculture field product majorly 2,4 D-Acid and many others, surfactants and cosmetic products as well as day to day personal use products, also used in Pigment.
About OCCL Ltd
OCCL Limited was incorporated on April 25, 2022, at Mundra, Kachchh, Gujarat with a Certificate of Incorporation issued by the RoC. The Company belongs to the AG Ventures Group of companies.
The Company's first insoluble sulphur manufacturing facility, (transferred from demerged entity), was set up in 1994 in Dharuhera to manufacture insoluble sulphur, now its flagship product.
The Company manufactures commercial grade and battery grade sulphuric acid and oleum at its Dharuhera Plant.
The Company's state-of-the-art manufacturing facilities are located in Dharuhera in Haryana and Mundra in Gujarat.
The Company commenced production of Sulphuric Acid in 1978; commenced production capacity of 3,000 MT per annum Insoluble Sulphur in 1994; established a second line of business at Dharuhera in 2005; commenced construction of plant at Mundra in 2009; commissioned the first line of 5500 MTPA at Mundra Plant in 2011; commissioned the second line of insoluble sulphur at Mundra with production capacity of 5500 MTPA in 2012; expanded the additional 11,000 TPA of insoluble sulphur capacity at Mundra in 2016; commissioned the third line of insoluble sulphur with installed capacity of 5500 MTPA at Mundra Plant in 2017; commissioned the fourth line of insoluble sulphur with 5500 MTPA at Mundra in 2018; commissioned the expansion of 5500 MTPA insoluble sulphur at Dharuhera Plant in 2021; commissioned an additional 42000 MTPA capacity of sulphuric acid at Dharuhera Plant in 2022.
FAQs for the comparison of Archit Organosys Ltd and OCCL Ltd
Which company has a larger market capitalization, Archit Organosys Ltd or OCCL Ltd?
Market cap of Archit Organosys Ltd is 75 Cr while Market cap of OCCL Ltd is 425 Cr
What are the key factors driving the stock performance of Archit Organosys Ltd and OCCL Ltd?
The stock performance of Archit Organosys Ltd and OCCL Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Archit Organosys Ltd and OCCL Ltd?
As of March 18, 2026, the Archit Organosys Ltd stock price is INR ₹36.57. On the other hand, OCCL Ltd stock price is INR ₹85.19.
How do dividend payouts of Archit Organosys Ltd and OCCL Ltd compare?
To compare the dividend payouts of Archit Organosys Ltd and OCCL Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.